Curaleaf Reports Significant Financial Highlights for 2024
Curaleaf Holdings, Inc. (TSX: CURA) (OTCQX: CURLF) has disclosed its impressive financial results for the fourth quarter and the full fiscal year of 2024, highlighting substantial revenue and operational metrics. This leading international provider of cannabis consumer products witnessed a remarkable total revenue of $331 million for the fourth quarter, demonstrating steady performance compared to the previous quarter.
Key Financial Metrics
During the fourth quarter, Curaleaf achieved a gross profit of $157.4 million, reflecting an adjusted gross margin of 48%. The company generated an operating cash flow of $163 million for the entire year. Free cash flow from continuing operations was reported at $70 million, marking a notable achievement in financial health and operational efficiency.
Fourth Quarter Financial Summary
- Net revenue of $331.1 million, representing a decrease of 4% year-over-year compared to the same period in 2023.
- Gross profit for the quarter was $157.4 million, achieving a gross margin increase of 230 basis points.
- Adjusted EBITDA reached $75.8 million, with a margin of 23%.
- Cash reserves at the end of the quarter totaled $107.2 million, indicating strong liquidity.
Annual Financial Overview
The full year revenue stood at $1.34 billion, flat compared to 2023, yet significant gains were noted in international revenue, which increased to $105.6 million—representing a 73% rise year-over-year.
Full Year Highlights
- Operating cash flow from continuing operations was $163.3 million.
- Gross profit was recorded at $639.2 million, maintaining a gross margin of 48%.
- Adjusted net loss from continuing operations was $116.8 million, with adjusted net loss per share standing at $0.16.
Operational Milestones
In 2024, Curaleaf expanded its operational footprint significantly, opening new dispensaries in various markets and introducing innovative products that contribute to the growing cannabis sector. The company successfully opened two new dispensaries in Florida, enhancing its retail presence.
Post Fourth Quarter Developments
- Business expansion continued with the launch of a new line of hemp-derived THC seltzers.
- Curaleaf reported rebranding efforts, aligning its Nevada stores under the Curaleaf name.
CEO Boris Jordan emphasized the importance of the company's strategic initiatives aimed at streamlining operations. He stated, "As we step into 2025, we are focused on sustaining our growth momentum, leveraging our innovation pipeline to drive sales in both existing and new markets." This reflects Curaleaf's commitment to enhancing product offerings and optimizing cash flow.
About Curaleaf Holdings
Curaleaf is dedicated to providing high-quality consumer products in the cannabis industry and is recognized for its innovation, operational reliability, and extensive distribution network across key regions. The company is continually working on enhancing its market position by introducing diverse cannabis products suitable for both medical and recreational users.
Frequently Asked Questions
What were Curaleaf's total revenues for the fourth quarter of 2024?
Curaleaf reported total revenues of $331 million for the fourth quarter of 2024.
How much cash did Curaleaf hold by the end of Q4 2024?
By the end of Q4 2024, Curaleaf had cash reserves totaling $107.2 million.
What is the adjusted EBITDA for Curaleaf in the fourth quarter of 2024?
Curaleaf's adjusted EBITDA for the fourth quarter of 2024 was $75.8 million, with an EBITDA margin of 23%.
How does Curaleaf's full-year revenue compare to the previous year?
The full-year revenue for Curaleaf was $1.34 billion, flat compared to the previous year.
What key initiatives is Curaleaf focused on for future growth?
Curaleaf is implementing its "Return to our ROOTS" initiative, centered around driving organic growth and optimizing operational efficiencies.
